IQVIA艾昆纬：2025年释放制药潜力：泰国诊所日益重要的作用报告（英文版）

Since the end of the COVID lockdown, the pharmaceutical market in Thailand has seen rapid growth within the clinics channel: both prescription (Rx) and over-the-counter drug sales are expanding at a faster rate compared to public hospitals, private hospitals, and pharmacies. For the top 15 multinational corporation (MNC) pharmaceuticals, sales across clinics have grown at a faster rate (25% compound annual growth rate [CAGR]) than those at private hospitals, public hospitals, and pharmacies.